Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C
Latest Information Update: 07 Jun 2022
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 10 May 2022 Status changed from active, no longer recruiting to discontinued.
- 16 Jul 2021 Planned End Date changed from 31 Mar 2021 to 31 Dec 2021.
- 30 Mar 2021 Status changed from recruiting to active, no longer recruiting.